Goodsurance
ES

Drug prices & Part D

About 140,000 Wellcare Part D Members Were Dropped Mid-Year After Small New Premiums Were Added to Their Previously Free Plans

KFF Health News found that Wellcare terminated tens of thousands of drug plan members in April 2026 when minimal monthly premiums went unpaid, leaving many without prescription coverage and at risk for permanent Medicare drug enrollment penalties.

By the Goodsurance editorial teamSeptember 21, 2026

KFF Health News reported in July 2026 that Wellcare Health Plans terminated approximately 140,000 members of its Value Script prescription drug plan in April 2026 after introducing a monthly premium to a plan that had been free for years. Many members did not pay the new charge, prompting mid-year disenrollment across 26 states and Washington, D.C.

The premium amounts involved were small. In Nevada, some members owed as little as 8 dollars and 10 cents for three months of accumulated unpaid charges. One beneficiary in the KFF Health News reporting saw his monthly premium rise from zero to 3 dollars and 60 cents.

Wellcare dropped about 140,000 Part D members mid-year after adding small new premiums to formerly free plans, leaving many at risk for permanent Medicare drug penalties, KFF Health News found.

Wellcare said roughly 40,000 of those terminated may qualify for the federal Extra Help program, also called the Low-Income Subsidy, which can allow immediate re-enrollment in a Part D plan. The remaining members generally cannot rejoin a drug plan until the fall annual enrollment period for 2027 coverage, absent a qualifying special enrollment event.

The financial stakes of a coverage gap are real. Under Medicare rules, people who go 63 or more consecutive days without creditable prescription drug coverage face a permanent monthly surcharge added to their future Part D premiums. The reporting illustrated the exposure: one beneficiary faced approximately 1,800 dollars for a 90-day supply of a blood thinner without Part D coverage.

KFF Health News also noted that the annual notice of changes disclosing the new premium ran 21 pages, raising questions about whether members had a realistic opportunity to notice and act before being dropped.

In plain words

A Medicare drug plan called Wellcare Value Script dropped about 140,000 members in April 2026. This happened in the middle of the year, not at the usual end-of-year enrollment period.

The plan had cost nothing for years. Then Wellcare added a small monthly fee. Many people did not know about it or did not pay. So Wellcare removed them. Some owed only a few dollars total.

This is serious. Under Medicare rules, if you go 63 days or more without drug coverage, you get a permanent penalty added to your future monthly premiums. And without a drug plan, medicines can cost a lot. One person in the news story had to pay about 1,800 dollars for a 90-day supply of a blood thinner.

About 40,000 of the dropped members may qualify for Extra Help, a program for lower-income people that can let them rejoin a plan right away. Others must wait for open enrollment this October.

The notice that explained the new premium was 21 pages long.

Source: KFF Health News
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

Third Medicare Drug Negotiation Cycle Closes, Including Part B Doctor-Office Drugs for the First Time

The formal negotiation period for 15 drugs ended November 1; CMS must publish any agreed-upon maximum fair prices by November 30, including the first-ever negotiated prices for drugs given in doctors' offices.

November 1, 2026

Drug prices & Part D

Average Medicare Part D Stand-Alone Premium Projected to Rise 50 Percent for 2027, KFF Finds

A KFF analysis published today finds the average monthly premium for stand-alone Part D drug plans is on track to climb from 34 dollars to 51 dollars for 2027, with deductibles also rising sharply, for enrollees who do not switch plans before December 7.

October 30, 2026

Drug prices & Part D

Study: Medicare Drug Price Negotiations Cut Costs for Most Enrollees, but Not for Those Already Hitting the Annual Spending Limit

A research letter in Annals of Internal Medicine finds that patients on six of the first ten negotiated Part D drugs saw out-of-pocket costs fall 26 to 49 percent, while patients on the three highest-priced negotiated drugs saw no additional benefit because they were already reaching the annual cap.

October 24, 2026

Drug prices & Part D

A Customs Rule That Would Have Complicated Drug Orders From Canada Is Delayed Three Months

A new paperwork and bonding requirement for international mail containing medications was set to take effect today but was pushed back to January 20, 2027, preserving a cost-saving pathway that many Medicare beneficiaries and other older adults have come to rely on.

October 22, 2026

Drug prices & Part D

CMS Proposes Eliminating the 1-Dollar Generic Drug Copay for the Lowest-Income Medicare Dual Enrollees

A proposed rule published today in the Federal Register would bring the Part D generic drug copayment to zero for full-benefit dual eligible individuals at or below the Federal Poverty Level, starting in 2028.

October 20, 2026

Drug prices & Part D

Drug Maker Agrees to Pay 4 Million Dollars for Billing Medicare Part D for an Eye Drop That Had Gone Over the Counter

Somerset Lifesciences continued labeling a generic antihistamine eye drop as prescription-only for more than three years after its brand equivalent became available without a prescription, causing Medicare to pay pharmacy claims for a drug the program does not cover.

October 19, 2026